EN
HI
Summary
As of 7 Nov, 2026, Novyra Pharmachem stock price is ₹7.68. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Novyra Pharmachem has traded between ₹7.68 and ₹16.55.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹7.68.
Novyra Pharmachem has an upper circuit limit of ₹8.06 and a lower circuit limit of ₹7.30. The total value traded stands at ₹0.00, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 100. Novyra Pharmachem also offers a dividend yield of 0%.
Novyra Pharmachem Share Price Chart
Novyra Pharmachem Share Key Metrics
Volume
0.00
Market Cap
4.86 CR
LTQ@LTP
0@7.68
ATP
0
Var Margin
100 %
Circuit Range
7.3-8.06
Delivery %
- %
Value
0.00
ASM/GSM
No
Market Lot
100
Novyra Pharmachem Resistance and Support
Pivot 7.68
Resistance
First Resistance
7.68
Second Resistance
7.68
Third Resistance
7.68
Support
First Support
7.68
Second Support
7.68
Third Support
7.68
Novyra Pharmachem Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 29 2026 | 7.67 | 7.67 | -4.96% | 7.67 | 7.67 |
| Wed Oct 28 2026 | 8.07 | 8.07 | -5.06% | 8.07 | 8.07 |
| Tue Oct 13 2026 | 8.5 | 8.5 | -2.41% | 8.5 | 8.5 |
Novyra Pharmachem Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-02 | Quarterly Results |
| 2026-08-14 | Quarterly Results |
| 2026-05-16 | Reduction of Capital |
| 2026-05-02 | Audited Results |
| 2026-04-29 | Audited Results |
| 2026-04-25 | Audited Results |
| 2026-04-18 | Audited Results |
| 2026-03-20 | Others |
| 2026-01-26 | Quarterly Results |
| 2026-01-22 | Quarterly Results |
| 2025-11-19 | Others |
| 2025-10-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-05-24 | Audited Results |
| 2025-02-05 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-07-30 | Quarterly Results |
| 2024-07-25 | Quarterly Results |
Novyra Pharmachem News
Novyra Pharmachem Ltd - 519353 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended September 30, 2026
Novyra Pharmachem reported Q2 FY27 revenue of ₹4.27 crores and a net loss of ₹3.33 lakhs. The pharma segment contributed ₹4.23 crores to the overall quarterly revenue.
Nov 02 2026 17:43:46
Novyra Pharmachem Ltd - 519353 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended On 30Th September 2026
Novyra Pharmachem's board will meet on 2 November 2026 to evaluate the financial results for the quarter ended 30 September 2026. The meeting will also consider any other business with the permission of the chairman.
Oct 23 2026 18:09:38
Novyra Pharmachem Management
| Name | Position |
|---|---|
| Sandeep Agarwal | Whole Time Director |
| Amit Mitruka | Non Executive Director |
Novyra Pharmachem Similar Stocks
Omega Ag-Seeds (Punjab) Ltd.
7.90
0.00 (0.00%)
Times Green Energy (India) Ltd.
70.99
6.98 (10.90%)
Shree Hanuman Sugar & Industries Ltd.
3.65
-0.15 (3.95%)
SC Agrotech Ltd.
48.90
2.32 (4.98%)
Thakkers Group Ltd.
32.57
0.00 (0.00%)
Retro Green Revolution Ltd.
1.25
0.02 (1.63%)
Kanel Industries Ltd.
86.06
4.09 (4.99%)
Beeyu Overseas Ltd.
2.50
0.00 (0.00%)
Natura Hue Chem Ltd.
49.78
0.97 (1.99%)
Novyra Pharmachem FAQs
The Buying Price of Novyra Pharmachem share is 7.68 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Novyra Pharmachem stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Novyra Pharmachem, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Novyra Pharmachem shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Novyra Pharmachem shares is 0. Useful to assess the stock's value relative to its book value.
To assess Novyra Pharmachem’s valuation compare Sector P/E, P/B which are 14.79 & 1.21 with sector averages, along with growth rates and financial metrics.
The Market Cap of Novyra Pharmachem is 4.86 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Novyra Pharmachem share price is 16.55 & 7.68. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Novyra Pharmachem belongs to the Agriculture sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NOVYRA
